DVA — DaVita Inc. stock price and chart

Share this page

DVA

$178.72+0.02%

as of close, Oct 5, 2026

☾ AH $178.72 +0.02%

DaVita Inc.Stock · HealthcareS&P 500 Equal Weight 0.2%S&P 500 0.01%Russell 1000 0.01%Russell 3000 0.010%US Stock Market 0.010%

PeersMRNALLYUNHJNJMRKTMO

Technical analysis2

Overlay lines0

Addendum charts0

VolumeEEEE

20162019202120242026

60.080.0100.0120.0140.0160.0180.0200.0220.0020.0M$178.72

2026-10-05

Price$178.72

MA20$194.33

MA50$156.59

Vol2.1M

What would $1,000 invested in DVA be worth today? →

DVA returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $178.72
YTD price return: +57.31%
YTD total return: +57.31%
Next earnings: Nov 4, 2026
Market cap: 11.4B2016-12 12.7B2026-10 11.4B-10.0% over the window
Enterprise value: 24.6B
Shares outstanding: 63.8M2016-06 206.9M2026-06 63.8M-69.2% over the window
52W low: $101.00
52W high: $247.49
From 52W high: -27.79%
From 52W low: +76.95%
52W range: 53%
Beta: 0.86

Volume

Rel volume: 0.67×
30D volume: 679.3K
30D $ vol: 123M

Insider trading

Insider net 1WNo open-market insider purchase or sale with a transaction date in the last 7 days, as filed on Form 4.: none
Insider net 1MNo open-market insider purchase or sale with a transaction date in the last 30 days, as filed on Form 4.: none
Insider net 3M0 insider-days of buying (no priced lot) and 1 of selling ($36.5M) in the last 91 days, by transaction date, open-market transactions only — awards, exercises, tax withholding and employee-plan purchases are not counted. A Form 4 is filed within two business days of the trade, so the newest days may not be in yet.: −$36.5M
Insider net 1Y0 insider-days of buying (no priced lot) and 11 of selling ($454.3M) in the last 365 days, by transaction date, open-market transactions only — awards, exercises, tax withholding and employee-plan purchases are not counted. A Form 4 is filed within two business days of the trade, so the newest days may not be in yet.: −$454.3M

Form 4 transactions by trade date, as filed; latest on file 2026-07-31.

Fundamentals

Sales (ttm): 14B2016-12 10.7B2026-06 14B+30.8% over the window
Sales/share: $219.592016-12 $55.022026-06 $219.59+299.1% over the window
EPS (ttm): $12.112016-06 $1.702026-06 $12.11+612.3% over the window
FCF (ttm): 1.6B2016-06 1.3B2026-06 1.6B+25.2% over the window
FCF/share: $25.232016-06 $6.212026-06 $25.23+306.1% over the window
Book value/share: -$11.992016-06 $22.942026-06 -$11.99-152.3% over the window
Net margin: 6.05%2016-12 8.2%2026-06 6.0%-26.4% over the window
ROA: 4.79%2016-06 1.9%2026-06 4.8%+148.0% over the window
Current ratio: 1.472016-06 1.702026-06 1.47-13.7% over the window

Growth (CAGR, ttm) · 10Y

Sales: +6.45%2025-06-30 → 2026-06-3013.2B → 14B (+6.4% total)+6.07%2023-06-30 → 2026-06-3011.7B → 14B (+19.3% total)+3.91%2021-06-30 → 2026-06-3011.6B → 14B (+21.1% total)+2.87%2016-12-31 → 2026-06-3010.7B → 14B (+30.8% total)
Net income: +1.34%2025-06-30 → 2026-06-30836.3M → 847.5M (+1.3% total)+21.91%2023-06-30 → 2026-06-30467.7M → 847.5M (+81.2% total)-0.38%2021-06-30 → 2026-06-30863.7M → 847.5M (-1.9% total)+8.92%2016-06-30 → 2026-06-30360.7M → 847.5M (+135.0% total)
FCF: +24.98%2025-06-30 → 2026-06-301.3B → 1.6B (+25.0% total)+5.87%2023-06-30 → 2026-06-301.4B → 1.6B (+18.7% total)+7.45%2021-06-30 → 2026-06-301.1B → 1.6B (+43.2% total)+2.28%2016-06-30 → 2026-06-301.3B → 1.6B (+25.2% total)
Shares: -10.78%2025-06-30 → 2026-06-3071.5M → 63.8M (-10.8% total)-11.26%2023-06-30 → 2026-06-3091.3M → 63.8M (-30.1% total)-9.45%2021-06-30 → 2026-06-30104.8M → 63.8M (-39.1% total)-11.10%2016-06-30 → 2026-06-30206.9M → 63.8M (-69.2% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: +18.84%2025-06-30 → 2026-06-30$10.19 → $12.11 (+18.8% total)+33.91%2023-06-30 → 2026-06-30$5.04 → $12.11 (+140.2% total)+10.03%2021-06-30 → 2026-06-30$7.51 → $12.11 (+61.2% total)+21.70%2016-06-30 → 2026-06-30$1.70 → $12.11 (+612.3% total)
Sales/share: +19.31%2025-06-30 → 2026-06-30$184.07 → $219.59 (+19.3% total)+19.53%2023-06-30 → 2026-06-30$128.57 → $219.59 (+70.8% total)+14.75%2021-06-30 → 2026-06-30$110.36 → $219.59 (+99.0% total)+15.69%2016-12-31 → 2026-06-30$55.02 → $219.59 (+299.1% total)
FCF/share: +40.08%2025-06-30 → 2026-06-30$18.02 → $25.23 (+40.0% total)+19.30%2023-06-30 → 2026-06-30$14.86 → $25.23 (+69.8% total)+18.66%2021-06-30 → 2026-06-30$10.73 → $25.23 (+135.2% total)+15.05%2016-06-30 → 2026-06-30$6.21 → $25.23 (+306.1% total)
Price: +39.63%2025-10-06 → 2026-10-05$128.14 → $178.72 (+39.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+25.11%2023-10-05 → 2026-10-05$91.25 → $178.72 (+95.9% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+9.22%2021-10-05 → 2026-10-05$114.99 → $178.72 (+55.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+10.75%2016-10-04 → 2026-10-05$64.34 → $178.72 (+177.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +39.63%2025-10-06 → 2026-10-05$128.14 → $178.72 (+39.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+25.11%2023-10-05 → 2026-10-05$91.25 → $178.72 (+95.9% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+9.22%2021-10-05 → 2026-10-05$114.99 → $178.72 (+55.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+10.75%2016-10-04 → 2026-10-05$64.34 → $178.72 (+177.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 14.8×2016-12 17.702026-10 13.45-24.0% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 5.4×2016-12 6.632026-10 5.36-19.2% over the window
Fwd P/E: 10.4×
P/S (ttm)Market cap ÷ TTM revenue.: 0.8×2017-03 1.252026-10 0.81-35.0% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: -14.9×2016-12 2.582026-10 -14.90-677.6% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 7.1×2016-12 11.552026-10 7.08-38.7% over the window
EV/EBITDA (fy): 8.9×
EV/Sales (ttm): 1.8×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 14.12%2016-09 8.7%2026-06 11.4%+31.2% over the window
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 63.8M ÷ 71.5M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: 10.78%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (10.78%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($10.2B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 10.78%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($892.4M) ÷ today's market cap ($11.4B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 7.83%2016-09 6.2%2026-06 6.3%+1.4% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $892.4M + TTM dividends $0) ÷ today's market cap ($11.4B). Same caveat as the cash buyback yield.: 7.83%2016-09 6.2%2026-06 6.3%+1.4% over the window

Vs own 10Y history

P/E: 42nd
P/OI: 26th
P/S: 34th
P/B: 98th
P/FCF: 24th

Bar = where today’s multiple sits in DVA’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-05#

+0.02%

+0.37%

-2.86%

-23.92%

YTD

+57.31%

+36.26%

+55.42%

Recent filings#

Aug 4Earnings · Earnings release — EPS $4.02 vs $4.01 est. (+0.3%); revenue $3.55B (+5% y/y) 17.2%
Aug 4Report · Quarterly report, Q2 2026 — revenue $3.55B (+5% y/y), net income $265.4M, EPS $4.02
Jul 31Insider sale · BERKSHIRE HATHAWAY INC, BUFFETT WARREN E (2 filers) sold 182,980 shares for $36.5M at $199.55
Jun 16Insider sale · Rodriguez Javier (Chief Executive Officer · Director) sold 39,407 shares for $8.2M at $209.28
Jun 15Insider sale · Rodriguez Javier (Chief Executive Officer · Director) sold 30,000 shares for $6.3M at $209.50

All filings and insider trades →

Financial statements

Open full DVA financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	-0.54%	+0.02%
JNJ	Johnson & Johnson	-8.10%	-1.21%
ABBV	AbbVie Inc.	+3.63%	+1.12%
MRK	Merck & Co. Inc.	-7.18%	-3.30%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	-4.67%	+1.80%
TMO	Thermo Fisher Scientific Inc.	+10.26%	+3.35%
AMGN	Amgen Inc.	-7.83%	-0.01%
GILD	Gilead Sciences Inc.	-4.22%	-0.08%

DVA — DaVita Inc. price, chart and key statistics